A team of researchers from Florida State University, Johns Hopkins University and the National Institutes of Health has found existing drug compounds that can both stop Zika from replicating in the body and from damaging the crucial fetal brain cells that lead to birth defects in newborns. One of the drugs is already on the market as a treatment for tapeworm. "We focused on compounds that have the shortest path to clinical use," said FSU Professor of Biological Science Hengli Tang. "This is a first step toward a therapeutic that can stop transmission of this disease." Tang, along with Johns...